The Independent emphasizes its role in delivering impactful journalism on pressing issues such as reproductive rights and climate change, ensuring the public receives comprehensive, fact-checked information. In partnership with GSK, the University of Oxford is pioneering a novel cancer vaccine focused on pre-cancerous cells. This initiative aims to prevent cancer before it develops, reflecting significant advancements in medical research. Led by Prof Sarah Blagden, the GSK-Oxford Cancer Immuno-Prevention Programme secures substantial funding to explore innovative solutions in cancer treatment.
We believe quality journalism should be available to everyone, paid for by those who can afford it.
The partnership intends to create a vaccine or vaccines which target cells at the pre-cancerous stage, before the disease has taken hold.
Collection
[
|
...
]